Logo image of LTHM

Livent Corporation (LTHM) Stock Fundamental Analysis

NYSE:LTHM - New York Stock Exchange, Inc. - US53814L1089 - Common Stock - Currency: USD

16.51  -1.54 (-8.53%)

After market: 16.3 -0.21 (-1.27%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LTHM. LTHM was compared to 84 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making LTHM a very profitable company, without any liquidiy or solvency issues. LTHM is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make LTHM suitable for value and growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

LTHM had positive earnings in the past year.
In the past year LTHM had a positive cash flow from operations.
LTHM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years LTHM had a positive operating cash flow.
LTHM Yearly Net Income VS EBIT VS OCF VS FCFLTHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M 400M

1.2 Ratios

LTHM has a better Return On Assets (15.89%) than 96.43% of its industry peers.
LTHM has a better Return On Equity (21.55%) than 86.90% of its industry peers.
LTHM has a better Return On Invested Capital (16.86%) than 94.05% of its industry peers.
Industry RankSector Rank
ROA 15.89%
ROE 21.55%
ROIC 16.86%
ROA(3y)3.83%
ROA(5y)7.29%
ROE(3y)5.38%
ROE(5y)10.24%
ROIC(3y)N/A
ROIC(5y)N/A
LTHM Yearly ROA, ROE, ROICLTHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 5 10 15 20 25

1.3 Margins

LTHM's Profit Margin of 40.77% is amongst the best of the industry. LTHM outperforms 98.81% of its industry peers.
LTHM's Profit Margin has improved in the last couple of years.
LTHM's Operating Margin of 51.57% is amongst the best of the industry. LTHM outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of LTHM has grown nicely.
Looking at the Gross Margin, with a value of 58.78%, LTHM belongs to the top of the industry, outperforming 94.05% of the companies in the same industry.
LTHM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 51.57%
PM (TTM) 40.77%
GM 58.78%
OM growth 3Y31.56%
OM growth 5Y5.62%
PM growth 3Y37.55%
PM growth 5Y22.59%
GM growth 3Y18.28%
GM growth 5Y2.71%
LTHM Yearly Profit, Operating, Gross MarginsLTHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LTHM is creating value.
Compared to 1 year ago, LTHM has more shares outstanding
LTHM has a better debt/assets ratio than last year.
LTHM Yearly Shares OutstandingLTHM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
LTHM Yearly Total Debt VS Total AssetsLTHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.47 indicates that LTHM is not in any danger for bankruptcy at the moment.
The Altman-Z score of LTHM (4.47) is better than 91.67% of its industry peers.
The Debt to FCF ratio of LTHM is 6.03, which is on the high side as it means it would take LTHM, 6.03 years of fcf income to pay off all of its debts.
LTHM has a Debt to FCF ratio of 6.03. This is in the better half of the industry: LTHM outperforms 64.29% of its industry peers.
LTHM has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, LTHM is doing good in the industry, outperforming 79.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.03
Altman-Z 4.47
ROIC/WACC1.91
WACC8.85%
LTHM Yearly LT Debt VS Equity VS FCFLTHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M 1B

2.3 Liquidity

LTHM has a Current Ratio of 3.46. This indicates that LTHM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.46, LTHM is in the better half of the industry, outperforming 79.76% of the companies in the same industry.
LTHM has a Quick Ratio of 1.99. This is a normal value and indicates that LTHM is financially healthy and should not expect problems in meeting its short term obligations.
LTHM has a Quick ratio of 1.99. This is in the better half of the industry: LTHM outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.46
Quick Ratio 1.99
LTHM Yearly Current Assets VS Current LiabilitesLTHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

8

3. Growth

3.1 Past

LTHM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.24%, which is quite impressive.
Measured over the past years, LTHM shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.22% on average per year.
The Revenue has grown by 28.38% in the past year. This is a very strong growth!
LTHM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.54% yearly.
EPS 1Y (TTM)82.24%
EPS 3Y50.23%
EPS 5Y36.22%
EPS Q2Q%7.32%
Revenue 1Y (TTM)28.38%
Revenue growth 3Y27.93%
Revenue growth 5Y18.54%
Sales Q2Q%-8.72%

3.2 Future

The Earnings Per Share is expected to grow by 30.99% on average over the next years. This is a very strong growth
LTHM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.07% yearly.
EPS Next Y41.69%
EPS Next 2Y14.68%
EPS Next 3Y17.85%
EPS Next 5Y30.99%
Revenue Next Year10.53%
Revenue Next 2Y11%
Revenue Next 3Y16.09%
Revenue Next 5Y19.07%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LTHM Yearly Revenue VS EstimatesLTHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
LTHM Yearly EPS VS EstimatesLTHM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.47, the valuation of LTHM can be described as very reasonable.
Based on the Price/Earnings ratio, LTHM is valued cheaper than 83.33% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.85, LTHM is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.03, the valuation of LTHM can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LTHM indicates a rather cheap valuation: LTHM is cheaper than 86.90% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of LTHM to the average of the S&P500 Index (34.98), we can say LTHM is valued rather cheaply.
Industry RankSector Rank
PE 8.47
Fwd PE 9.03
LTHM Price Earnings VS Forward Price EarningsLTHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LTHM is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
LTHM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 73.71
EV/EBITDA 6.15
LTHM Per share dataLTHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LTHM has an outstanding profitability rating, which may justify a higher PE ratio.
LTHM's earnings are expected to grow with 17.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)0.23
EPS Next 2Y14.68%
EPS Next 3Y17.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LTHM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Livent Corporation

NYSE:LTHM (1/3/2024, 8:08:28 PM)

After market: 16.3 -0.21 (-1.27%)

16.51

-1.54 (-8.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31 2023-10-31/amc
Earnings (Next)02-12 2024-02-12/amc
Inst Owners0.94%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap2.97B
Analysts78.4
Price Target24.83 (50.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.12%
Min EPS beat(2)-6.14%
Max EPS beat(2)6.38%
EPS beat(4)3
Avg EPS beat(4)13.31%
Min EPS beat(4)-6.14%
Max EPS beat(4)49.43%
EPS beat(8)7
Avg EPS beat(8)17.45%
EPS beat(12)9
Avg EPS beat(12)-2.18%
EPS beat(16)9
Avg EPS beat(16)-58.9%
Revenue beat(2)0
Avg Revenue beat(2)-15.66%
Min Revenue beat(2)-22.75%
Max Revenue beat(2)-8.57%
Revenue beat(4)1
Avg Revenue beat(4)-8.8%
Min Revenue beat(4)-22.75%
Max Revenue beat(4)6.45%
Revenue beat(8)4
Avg Revenue beat(8)-3.59%
Revenue beat(12)7
Avg Revenue beat(12)-0.31%
Revenue beat(16)8
Avg Revenue beat(16)-2.88%
PT rev (1m)-6.33%
PT rev (3m)-22.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-31.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.67%
Valuation
Industry RankSector Rank
PE 8.47
Fwd PE 9.03
P/S 3.23
P/FCF 73.71
P/OCF 7.65
P/B 1.71
P/tB 1.71
EV/EBITDA 6.15
EPS(TTM)1.95
EY11.81%
EPS(NY)1.83
Fwd EY11.07%
FCF(TTM)0.22
FCFY1.36%
OCF(TTM)2.16
OCFY13.07%
SpS5.11
BVpS9.67
TBVpS9.67
PEG (NY)0.2
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 15.89%
ROE 21.55%
ROCE 21.35%
ROIC 16.86%
ROICexc 17.76%
ROICexgc 17.77%
OM 51.57%
PM (TTM) 40.77%
GM 58.78%
FCFM 4.38%
ROA(3y)3.83%
ROA(5y)7.29%
ROE(3y)5.38%
ROE(5y)10.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y25.49%
ROICexcg growth 5Y-6.33%
ROICexc growth 3Y25.52%
ROICexc growth 5Y-6.24%
OM growth 3Y31.56%
OM growth 5Y5.62%
PM growth 3Y37.55%
PM growth 5Y22.59%
GM growth 3Y18.28%
GM growth 5Y2.71%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.03
Debt/EBITDA 0.48
Cap/Depr 1167.79%
Cap/Sales 37.82%
Interest Coverage 41.26
Cash Conversion 77%
Profit Quality 10.74%
Current Ratio 3.46
Quick Ratio 1.99
Altman-Z 4.47
F-Score7
WACC8.85%
ROIC/WACC1.91
Cap/Depr(3y)745.91%
Cap/Depr(5y)706.61%
Cap/Sales(3y)38.61%
Cap/Sales(5y)35.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.24%
EPS 3Y50.23%
EPS 5Y36.22%
EPS Q2Q%7.32%
EPS Next Y41.69%
EPS Next 2Y14.68%
EPS Next 3Y17.85%
EPS Next 5Y30.99%
Revenue 1Y (TTM)28.38%
Revenue growth 3Y27.93%
Revenue growth 5Y18.54%
Sales Q2Q%-8.72%
Revenue Next Year10.53%
Revenue Next 2Y11%
Revenue Next 3Y16.09%
Revenue Next 5Y19.07%
EBIT growth 1Y113.26%
EBIT growth 3Y68.31%
EBIT growth 5Y25.2%
EBIT Next Year53.07%
EBIT Next 3Y22.01%
EBIT Next 5Y31.97%
FCF growth 1Y207.18%
FCF growth 3YN/A
FCF growth 5Y65.81%
OCF growth 1Y747.82%
OCF growth 3Y98.54%
OCF growth 5Y50.8%